Literature DB >> 27149548

Using CRISPR/Cas to study gene function and model disease in vivo.

Darjus F Tschaharganeh1, Scott W Lowe1,2, Ralph J Garippa3, Geulah Livshits1.   

Abstract

The recent discovery of the CRISPR/Cas system and repurposing of this technology to edit a variety of different genomes have revolutionized an array of scientific fields, from genetics and translational research, to agriculture and bioproduction. In particular, the prospect of rapid and precise genome editing in laboratory animals by CRISPR/Cas has generated an immense interest in the scientific community. Here we review current in vivo applications of CRISPR/Cas and how this technology can improve our knowledge of gene function and our understanding of biological processes in animal models.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  CRISPR/Cas9; cancer; disease models; genome editing; mouse models

Mesh:

Year:  2016        PMID: 27149548      PMCID: PMC5120361          DOI: 10.1111/febs.13750

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  70 in total

1.  Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

Authors:  F Ann Ran; Patrick D Hsu; Chie-Yu Lin; Jonathan S Gootenberg; Silvana Konermann; Alexandro E Trevino; David A Scott; Azusa Inoue; Shogo Matoba; Yi Zhang; Feng Zhang
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

2.  Deletions, Inversions, Duplications: Engineering of Structural Variants using CRISPR/Cas in Mice.

Authors:  Katerina Kraft; Sinje Geuer; Anja J Will; Wing Lee Chan; Christina Paliou; Marina Borschiwer; Izabela Harabula; Lars Wittler; Martin Franke; Daniel M Ibrahim; Bjørt K Kragesteen; Malte Spielmann; Stefan Mundlos; Darío G Lupiáñez; Guillaume Andrey
Journal:  Cell Rep       Date:  2015-02-07       Impact factor: 9.423

Review 3.  Endonucleases: new tools to edit the mouse genome.

Authors:  Tobias Wijshake; Darren J Baker; Bart van de Sluis
Journal:  Biochim Biophys Acta       Date:  2014-04-30

4.  Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos.

Authors:  Yuyu Niu; Bin Shen; Yiqiang Cui; Yongchang Chen; Jianying Wang; Lei Wang; Yu Kang; Xiaoyang Zhao; Wei Si; Wei Li; Andy Peng Xiang; Jiankui Zhou; Xuejiang Guo; Ye Bi; Chenyang Si; Bian Hu; Guoying Dong; Hong Wang; Zuomin Zhou; Tianqing Li; Tao Tan; Xiuqiong Pu; Fang Wang; Shaohui Ji; Qi Zhou; Xingxu Huang; Weizhi Ji; Jiahao Sha
Journal:  Cell       Date:  2014-01-30       Impact factor: 41.582

5.  Single-Step Generation of Conditional Knockout Mouse Embryonic Stem Cells.

Authors:  Matyas Flemr; Marc Bühler
Journal:  Cell Rep       Date:  2015-07-16       Impact factor: 9.423

6.  Small molecules enhance CRISPR genome editing in pluripotent stem cells.

Authors:  Chen Yu; Yanxia Liu; Tianhua Ma; Kai Liu; Shaohua Xu; Yu Zhang; Honglei Liu; Marie La Russa; Min Xie; Sheng Ding; Lei S Qi
Journal:  Cell Stem Cell       Date:  2015-02-05       Impact factor: 24.633

7.  Life in the fast lane: mammalian disease models in the genomics era.

Authors:  Lukas E Dow; Scott W Lowe
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

8.  A rapid and scalable system for studying gene function in mice using conditional RNA interference.

Authors:  Prem K Premsrirut; Lukas E Dow; Sang Yong Kim; Matthew Camiolo; Colin D Malone; Cornelius Miething; Claudio Scuoppo; Johannes Zuber; Ross A Dickins; Scott C Kogan; Kenneth R Shroyer; Raffaella Sordella; Gregory J Hannon; Scott W Lowe
Journal:  Cell       Date:  2011-04-01       Impact factor: 41.582

9.  Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing.

Authors:  Dirk Heckl; Monika S Kowalczyk; David Yudovich; Roger Belizaire; Rishi V Puram; Marie E McConkey; Anne Thielke; Jon C Aster; Aviv Regev; Benjamin L Ebert
Journal:  Nat Biotechnol       Date:  2014-06-22       Impact factor: 54.908

10.  Repurposing CRISPR/Cas9 for in situ functional assays.

Authors:  Abba Malina; John R Mills; Regina Cencic; Yifei Yan; James Fraser; Laura M Schippers; Marilène Paquet; Josée Dostie; Jerry Pelletier
Journal:  Genes Dev       Date:  2013-12-01       Impact factor: 11.361

View more
  17 in total

Review 1.  Genomic evolution of cancer models: perils and opportunities.

Authors:  Uri Ben-David; Rameen Beroukhim; Todd R Golub
Journal:  Nat Rev Cancer       Date:  2019-02       Impact factor: 60.716

Review 2.  The past and presence of gene targeting: from chemicals and DNA via proteins to RNA.

Authors:  T M Geel; M H J Ruiters; R H Cool; L Halby; D C Voshart; L Andrade Ruiz; K E Niezen-Koning; P B Arimondo; M G Rots
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-06-05       Impact factor: 6.237

Review 3.  CRISPR Editing Technology in Biological and Biomedical Investigation.

Authors:  Martyn K White; Rafal Kaminski; Won-Bin Young; Pamela C Roehm; Kamel Khalili
Journal:  J Cell Biochem       Date:  2017-07-04       Impact factor: 4.429

Review 4.  Cancer diagnosis and immunotherapy in the age of CRISPR.

Authors:  Peter J Cook; Andrea Ventura
Journal:  Genes Chromosomes Cancer       Date:  2018-12-20       Impact factor: 5.006

Review 5.  Emerging applications of genome-editing technology to examine functionality of GWAS-associated variants for complex traits.

Authors:  Andrew J P Smith; Panos Deloukas; Patricia B Munroe
Journal:  Physiol Genomics       Date:  2018-04-13       Impact factor: 3.107

6.  Direct genome editing of patient-derived xenografts using CRISPR-Cas9 enables rapid in vivo functional genomics.

Authors:  Christopher H Hulton; Emily A Costa; Nisargbhai S Shah; Alvaro Quintanal-Villalonga; Glenn Heller; Elisa de Stanchina; Charles M Rudin; John T Poirier
Journal:  Nat Cancer       Date:  2020-03-09

7.  Tissue-specific activation of gene expression by the Synergistic Activation Mediator (SAM) CRISPRa system in mice.

Authors:  Charleen Hunt; Suzanne A Hartford; Derek White; Evangelos Pefanis; Timothy Hanna; Clarissa Herman; Jarrell Wiley; Heather Brown; Qi Su; Yurong Xin; Dennis Voronin; Hien Nguyen; Judith Altarejos; Keith Crosby; Jeffery Haines; Sarah Cancelarich; Meghan Drummond; Sven Moller-Tank; Ryan Malpass; Jacqueline Buckley; Maria Del Pilar Molina-Portela; Gustavo Droguett; David Frendewey; Eric Chiao; Brian Zambrowicz; Guochun Gong
Journal:  Nat Commun       Date:  2021-05-13       Impact factor: 14.919

8.  Epigenetic Targeting of Granulin in Hepatoma Cells by Synthetic CRISPR dCas9 Epi-suppressors.

Authors:  Hong Wang; Rui Guo; Zhonghua Du; Ling Bai; Lingyu Li; Jiuwei Cui; Wei Li; Andrew R Hoffman; Ji-Fan Hu
Journal:  Mol Ther Nucleic Acids       Date:  2018-01-08       Impact factor: 8.886

Review 9.  Patterns of CRISPR/Cas9 activity in plants, animals and microbes.

Authors:  Luisa Bortesi; Changfu Zhu; Julia Zischewski; Lucia Perez; Ludovic Bassié; Riad Nadi; Giobbe Forni; Sarah Boyd Lade; Erika Soto; Xin Jin; Vicente Medina; Gemma Villorbina; Pilar Muñoz; Gemma Farré; Rainer Fischer; Richard M Twyman; Teresa Capell; Paul Christou; Stefan Schillberg
Journal:  Plant Biotechnol J       Date:  2016-10-11       Impact factor: 9.803

10.  Safety and Efficacy of AAV Retrograde Pancreatic Ductal Gene Delivery in Normal and Pancreatic Cancer Mice.

Authors:  Kayla A Quirin; Jason J Kwon; Arafat Alioufi; Tricia Factora; Constance J Temm; Max Jacobsen; George E Sandusky; Kim Shontz; Louis G Chicoine; K Reed Clark; Joshua T Mendell; Murray Korc; Janaiah Kota
Journal:  Mol Ther Methods Clin Dev       Date:  2017-09-30       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.